Self instill push housing eye drop dispenser
Latest Allergan Sales, Inc. Patents:
- GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
- Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
- Calcium blockers to treat proliferative vitreoretinopathy
- GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
- Pain treatment by peripheral administration of a neurotoxin
Description
FIG. 1 is a top, front and left side perspective view of a self instill push housing eye drop dispenser showing my new design;
FIG. 2 is a front elevational view;
FIG. 3 is a left side elevation view and the right side is an exact mirror image of the left side;
FIG. 4 is a back elevational view;
FIG. 5 is a top plan view; and,
FIG. 6 is a bottom plan view.
Claims
The ornamental design for a self instill push housing eye drop dispenser, as shown and described.
Referenced Cited
Patent History
Patent number: D445177
Type: Grant
Filed: Jul 31, 2000
Date of Patent: Jul 17, 2001
Assignee: Allergan Sales, Inc. (Irvine, CA)
Inventor: John J. Cogger (Irvine, CA)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Walter A. Hackler
Application Number: 29/127,140
Type: Grant
Filed: Jul 31, 2000
Date of Patent: Jul 17, 2001
Assignee: Allergan Sales, Inc. (Irvine, CA)
Inventor: John J. Cogger (Irvine, CA)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Walter A. Hackler
Application Number: 29/127,140
Classifications
Current U.S. Class:
Eye Cup (D24/120);
D9/529;
Receptacle Or Vessel (14) (D24/121)
International Classification: 2402;
International Classification: 2402;